Menu Search
Equities

TriSalus Life Sciences Inc

TLSI:NMQ

TriSalus Life Sciences Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)4.50
  • Today's Change0.04 / 0.90%
  • Shares traded15.07k
  • 1 Year change+12.22%
  • Beta0.5438
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year TriSalus Life Sciences Inc had net income fall 25.11% from a loss of 47.19m to a larger loss of 59.04m despite a 49.31% increase in revenues from 12.40m to 18.51m. An increase in the selling, general and administrative costs as a percentage of sales from 203.43% to 219.04% was a component in the falling net income despite rising revenues.
Gross margin87.65%
Net profit margin-219.71%
Operating margin-212.06%
Return on assets-220.73%
Return on equity--
Return on investment-2,149.76%
More ▼

Cash flow in USDView more

In 2023, TriSalus Life Sciences Inc increased its cash reserves by 25.49%, or 2.46m. Cash Flow from Financing totalled 54.63m or 295.12% of revenues. In addition the company used 50.05m for operations while cash used for investing totalled 2.12m.
Cash flow per share-1.91
Price/Cash flow per share--
Book value per share-0.8892
Tangible book value per share-0.9301
More ▼

Balance sheet in USDView more

TriSalus Life Sciences Inc uses little or no debt in its capital structure.
Current ratio2.33
Quick ratio2.04
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.